Exposure to arsenic-laden drinking water can induce symptoms of gastroenteritis and lead to cancer, diabetes, and neurological and vascular dysfunction. Long-term arsenic exposure in drinking water shows a dose-response relationship to carotid atherosclerosis. The mechanism involves the induction of expression of genes coding inflammatory mediators. Arsenic has also been linked to dermatosis and cancers of the skin, bladder, and lung. Dietary arsenic is contributed by various foods including cereals and breads, 18.1%; starchy vegetables, 14.9%; and meats and fish, 32.1% of total average daily intake. Arsenic exposure is associated with the following clinical symptoms: → Neurological: Central depression with visual effects, headache and high fever → Hematological: Abnormal RBC counts, increased megalocytes and microcytes → GI tract: Increased peristalsis with “rice water” stools → Skin: “Milk and roses” complexion from vasodilation, darkening and degeneration Laboratory values of arsenic represent both the toxic form of arsenic and the non-toxic form of arsenic. Because seafood is rich in the non-toxic form of arsenic, the clinician should rule out ingestion of seafood in cases of borderline or moderate arsenic elevation before implementing aggressive therapy. Urinary arsenic is most commonly measured to screen for arsenic exposure. Urine reflects arsenic exposure in the few days prior to specimen collection. To eliminate the contribution of seafood to total arsenic levels, avoid seafood 72 hours before test. Hair, nail and urinary arsenic levels have been shown to be comparable. Hair or nail arsenic represents several months of exposure prior to taking the specimen. Hair arsenic greater than 1 μg/g dry weight has been taken to indicate excessive exposure. Since elevated arsenic in the serum drops within 6 to 10 hours, serum is not the best specimen for determining chronic arsenic exposure. Whole blood is suitable for identifying acute exposure to arsenic, and high levels should be addressed immediately. When arsenic toxicity is suspected, arsenic levels in drinking water should be measured. Support clearance of arsenic with B vitamins, especially folate. Give sulfur amino acids, antioxidants, as well as essential elements. Emblica officinalis, a medicinal plant, has shown promising results in animal studies. Associated Symptoms and Diseases: Peripheral arteriosclerosis (“blackfoot disease”) “ricewater” stools, proteinuria, hyperkeratosis, “milk and roses” hyperpigmentation, garlic breath odor, stomatitis Sources: Metal foundry, drinking water, seafood, glues, industrial exposure, contaminated wine, contaminated herbal supplements, cigarette smoke, arsenic-treated wood Protective Measures: Selenium, Emblica officinalis, sulfur amino acids, glutathione Chelating Agents: DMSA, DMPS, DMPA
Detection of nonacute arsenic exposure in hair specimens
Toxic Elements
What is Arsenic? Arsenic is a naturally occurring element found in soil, rocks, groundwater, and some foods. It exists in two main forms: Inorganic arsenic – the more toxic form, found in polluted groundwater, old pesticides, wood preservatives, and certain industrial processes. Organic arsenic – less toxic, mainly found in seafood like shellfish and seaweed. Most people encounter small amounts of arsenic daily through food and water. But when exposure is elevated or prolonged, arsenic can become harmful. The urine arsenic test (µg/g creatinine) is a reliable way to assess recent arsenic exposure. Common Sources of Exposure Water: wells or groundwater contaminated with inorganic arsenic Food: rice, grains, leafy vegetables, and seafood (especially shellfish and seaweed) Workplace: mining, smelting, glassmaking, or pesticide use Environment: regions with naturally high arsenic in soil or water Household: older pesticides or pressure-treated wood Why Arsenic Exposure Matters Arsenic is a toxic heavy metal that can affect nearly every organ system. Risks increase with long-term or high-level exposure: Skin problems: rashes, pigmentation changes, thickened skin Digestive upset: nausea, vomiting, abdominal pain, diarrhea Neurological symptoms: fatigue, brain fog, tingling in hands/feet, headaches Immune suppression: more frequent infections, slower recovery Organ stress: kidney and liver damage Cardiovascular harm: high blood pressure, vascular damage, heart disease Cancer: strong links to skin, bladder, and lung cancers from chronic inorganic arsenic exposure Vulnerable groups include children, pregnant women, and individuals with impaired detoxification capacity. Health Effects by Exposure Short-term (acute) exposure: nausea, vomiting, diarrhea, abdominal cramps, confusion, seizures (in severe cases) Chronic (long-term) exposure: skin lesions, anemia, immune dysfunction, cardiovascular disease, diabetes, developmental delays, and cancer risk Because arsenic can accumulate in the body over time, even moderate exposure may contribute to long-term health problems. Why Test for Arsenic? A urine arsenic test is especially important if you: Live in an area with known arsenic contamination or rely on well water Eat diets high in rice, seafood, or grains Work in industries with metals, pesticides, or glass manufacturing Have chronic symptoms such as fatigue, brain fog, digestive issues, or skin changes Are undergoing a Heavy Metals or Total Tox Burden panel Want to track detox progress after reducing exposure Key Takeaway & How to Lower Risk Elevated arsenic in urine means recent or ongoing exposure—usually from contaminated water, food, or workplace contact. While low-level exposure is common, high or chronic exposure increases risks of immune dysfunction, organ stress, and cancer. Steps to lower your risk: Drink filtered water (reverse osmosis or activated alumina systems are effective) Choose low-arsenic rice and limit seaweed or shellfish from unverified sources Avoid contact with arsenic-treated wood or old pesticides Support detox with hydration, a nutrient-rich diet, and medical guidance If your test shows elevated arsenic, consult a healthcare provider experienced in environmental or heavy metal medicine for next steps.
Toxic heavy metal
Highly toxic in its inorganic form.
Toxic Elements
The "Arsenic, Blood" marker on the "Heavy Metals Profile I, Blood" panel from LabCorp is a crucial test for assessing exposure to arsenic, a toxic heavy metal with significant health implications. Arsenic exposure can occur through various means, including contaminated water, certain foods, industrial processes, and occupational exposure in industries like mining and smelting. Measuring arsenic levels in blood is essential for detecting recent exposure, as arsenic is rapidly cleared from the bloodstream and redistributed to organs and tissues. Elevated blood arsenic levels can lead to acute symptoms like gastrointestinal distress, cardiac problems, and severe skin manifestations. Chronic exposure, even at lower levels, is particularly concerning, as it can result in long-term health issues like skin lesions, increased risk of cancers (especially skin, bladder, and lung), cardiovascular diseases, and neurotoxicity. For certain forms of organic arsenic, such as those found in seafood, the toxicity is much lower, and these forms are rapidly eliminated from the body; however, inorganic arsenic, found in contaminated water and certain foods, is highly toxic. The "Arsenic, Blood" test is therefore vital for distinguishing between these forms and understanding the exposure context. In cases of elevated arsenic levels, immediate steps are taken to reduce and eliminate exposure, and depending on the severity, treatments may include chelation therapy, which helps remove arsenic from the body. Continuous monitoring and follow-up testing are crucial for ensuring the effectiveness of these interventions and preventing further exposure.
Highly toxic in its inorganic form.
an endogenous molecule associated with joints
Elevated antibody levels can be clinically significant — while the antibodies themselves don’t destroy anything, they do trigger an inflammatory response that can cause significant destruction of tissue and resulting symptoms. This response is not necessarily dependent on antibody levels. However, an equivocal result may mean you are just beginning to exhibit an immune reaction, so this is an important time to take measures to support the body in damping immune reactivity. How useful is this test? Immunoglobulin G (IgG) food testing is a useful guide for structuring elimination diets for people with many chronic conditions. Individuals with neurological, gastrointestinal, movement, and behavioral disorders often suffer from IgG food sensitivities. People may continue to eat offending foods unaware of their potential adverse effects. The clinical significance of IgG food testing was illustrated in an early article published by an otolaryngologist who reported that the majority of his patients had substantial health improvements after eliminating foods found positive by IgG food allergy testing. The study demonstrated a 71% success rate for all symptoms, achieving at least a 75% relief. Of particular interest was the group of patients with chronic, disabling symptoms, unresponsive to other intensive treatments. Symptoms most commonly improved (75%-100%) on the elimination diets included asthma, coughing, ringing in the ears, chronic fatigue, headaches, gas, bloating, diarrhea, skin rash and itching, and nasal congestion. The most common IgG food allergies were to cow’s milk, garlic, mustard, egg yolk, tea, and chocolate. A recent study reported that 93% of non-celiac, gluten-sensitive patients showed anti-gliadin IgG antibody disappearance after a six-month adherence to a gluten-free diet. The IgG disappearance was closely related to a significant improvement of both gastrointestinal and extra-intestinal symptoms. High IgG antibody levels have frequently been found in children with diabetes mellitus, Crohn’s disease, celiac disease, and in those considered to be obese. IgG versus IgE Symptoms associated with food sensitivities may occur hours or days after the offending food was eaten because IgG food antibodies remain for a much longer time than IgE antibodies. IgE food allergy causes the release of histamine, producing an immediate hypersensitivity reaction. In contrast, IgG food sensitivity is triggered by the binding of complement to IgG food antigen complexes, causing an inflammatory response. This is a delayed hypersensitivity reaction in which symptoms appear anywhere from hours to days after eating the offending food. References: - Anderson S, Wakeley P, Wibberley G, et al. Development and evaluation of a Luminex multiplex serology assay to detect antibodies to bovine herpes virus 1, parainfluenza 3 virus, bovine viral diarrhoea virus, and bovine respiratory syncytial virus, with comparison to existing ELISA detection methods. J Immunol Methods 2011;366:79-88. - Gimenez-Lirola LG, Jiang Y-H, Sun D, et al. Simultaneous Detection of Antibodies against Apx Toxins ApxI, ApxII, ApxIII, and ApxIV in Pigs with Known and Unknown Actinobacillus pleuropneumoniae Exposure Using a Multiplexing Liquid Array Platform. Clin Vaccine Immunol 2014;21(1):85-95. - Langenhorst RJ, Lawson S, Kittawornrat A, et al. Development of a fluorescent microsphere immunoassay for detection of antibodies against porcine reproductive and respiratory syndrome virus using oral fluid samples as an alternative to serum-based assays. Clin Vaccine Immunol 2012;19(2):180-9. - Smits GP, van Gageldonk PG, Schouls LM, et al. Development of a BeadBased Multiplex Immunoassay for Simultaneous Quantitative Detection of IgG Serum Antibodies against Measles, Mumps, Rubella, and Varicella-Zoster Virus. Clin Vaccine Immunol 2012;19(3):396-400. - Alpay, K. et al. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia : an international journal of headache 30, 829-837, doi:10.1177/0333102410361404 (2010). - Mitchell, N. et al. Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches. Nutrition journal 10, 85, doi:10.1186/1475-2891-10-85 (2011). - Zar, S., Mincher, L., Benson, M. J. & Kumar, D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scandinavian journal of gastroenterology 40, 800-807, doi:10.1080/00365520510015593 (2005). - Atkinson, W., Sheldon, T. A., Shaath, N. & Whorwell, P. J. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 53, 1459-1464, doi:10.1136/gut.2003.037697 (2004). - Drisko, J., Bischoff, B., Hall, M. & McCallum, R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. Journal of the American College of Nutrition 25, 514-522 (2006). - Bentz, S. et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: a double-blind cross-over diet intervention study. Digestion 81, 252-264, doi:10.1159/000264649 (2010). - Egger, J., Carter, C. M., Soothill, J. F. & Wilson, J. Oligoantigenic diet treatment of children with epilepsy and migraine. The Journal of pediatrics 114, 51-58 (1989). - Pelsser, L. M. et al. Effects of a restricted elimination diet on the behavior of children with attention-deficit hyperactivity disorder (INCA study): a randomized controlled trial. Lancet 377, 494-503, doi:10.1016/S0140- 6736(10)62227-1 (2011). 8b cookbook - Veling, M. & Trevino, R. (2002). Food allergies and hypersensitivities. Alexandria, VA: American Academy of Otolaryngology-Head and Neck Surgery Foundation. - Dixon H, Treatment of delayed food allergy based on specific immunoglobulin G RAST testing relief. Otoloryngol Head Neck Surg 2000;123:48- 54. - Ciao, G. et al, Effect of gluten free diet on immune response to gliadin in patients with non-celiac gluten sensitivity. BMC Gastroenterology 14, 26 (2014) - Kemeny DM, et al Sub-class of IgG in allergic disease. I. IgG sub-class antibodies in immediate and non-immediate food allergy. Clin Allergy. 1986; 16:571-81 - Hofman, T. IgE and IgG antibodies in children with food allergy. Rocz Akad Med Bialymst 40, 468-473 (1995). - Jenmalm, M. C. & Bjorksten, B. Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 30, 34-40 (2000). - Lucarelli, S. et al. Food allergy in cystic fibrosis. Minerva pediatrica 46, 543-548 (1994). - van der Woude, F. J. et al. Do food antigens play a role in the pathogenesis of some cases of human glomerulonephritis? Clinical and experimental immunology 51, 587-594 (1983). - James L.K and Till S.J Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions. Current Allergy Asthma Rep. 16:23, 2016 PMID: 26892721 - Caubet J.C. et al. Natural tolerance development in cow’s milk allergic children: IgE and IgG4 epitope binding. European Journal of Allergy and Clinical Immunology, First published: 27 March 2017
Function: Saccharomyces cerevisae, baker’s yeast, contains Chl1p, a putative helicase with human homologs (antiSaccharamyces cerevisae antibody – ASCA), which is required for DNA repair, recombination, transcriptional silencing and aging. Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies against antigens in the cytoplasm of neutrophil granulocytes and monocytes. Antibodies Appear: Behçet’s Syndrome with GI Involvement Crohn’s Disease Long-term use of Anti-Thyroid Medication Ulcerative Colitis5 Vasculitis Clinical Significance: Crohn’s disease (CD) and Behçet’s syndrome (BS) have clinical similarities such as oral and gastrointestinal ulcerations, erythema nodosum, arthritis and uveitis. Patients with BS who present with gastrointestinal complaints have higher levels of ASCA than BS patients with no GI conditions. Vasculitides, associated with serum positivity for ANCAs affecting small- to medium-sized vessels, are commonly recognized as ANCA-associated vasculitis. ANCAs are detected in a number of autoimmune disorders, but are particularly associated with systemic vasculitis. ANCA positivity has been shown in a high percentage of patients on long-term anti-thyroid medication; therefore, ANCA should be tested in patients receiving long-term anti-thyroid medications, and in patients with adverse reactions. Furthermore, patients with positive ANCA should be followed, and evaluated for definitive anti-thyroid therapy, to consider alternative treatment protocols. ASCA and ANCA are well-established markers in inflammatory bowel disease (IBD), and both may be associated with disease phenotype. In support of diagnosis of Ulcerative Colitis, the sensitivity and specificity of ANCA were 51% and 100%, respectively. ASCA presented sensitivity of 62% and specificity of 93% for Crohn’s disease. References: 1. Fresko, et al. Anti-Saccharomyces cerevisae antibodies (ASCA) in Behçet’s syndrome. Clin Exp Rheumatol, 2005; 23(Suppl.38):S67-S70. 2. Gómez-Puerta, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest, 2009; 136:1011-1111. 3. Gunton, et al. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol, 2000; 142:587-590. 4. Lindberg, et al. Antibody (IgG, IgA, and IgM) to baker’s yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut, 1992; 33(7):909–913. 5. Nisihara, et al. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Dig Dis Sci, 2010; 55(8):2309-2315. 6. Seibold, et al. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol, 1998; 18(2):153-160.
ASCA IgA is an antibody against baker's/brewer's yeast that appears more often in Crohn's disease than in ulcerative colitis, helping tell the two apart.